Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Leveraging a Novel Machine Learning Method to Predict Outcomes in Latin American (LATAM) Patients with Newly Diagnosed T and NK Cell Lymphomas (TNKL)

Blood (2024) 144 (Supplement 1): 7515.

https://doi.org/10.1182/blood-2024-208856

Published: 2024

Journal Articles

Using Polatuzumab Plus Chemotherapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real-World Study from the Grupo De Estudio De Linfoproliferativos De Latinoamerica (GELL)

Blood (2024) 144 (Supplement 1): 1718.

https://doi.org/10.1182/blood-2024-211584

Published: 2024

Journal Articles

Central Nervous System Involvement in Aggressive ATLL: Can We Predict the Risk in a Devastating Complication? Epidemiology and Clinical Features from Latin America. a Collaborative Study from Grupo De Estudio Latino-Americano De Linfoproliferativo (GELL) & T-Cell Brazil Project (TCBP)

Natalia Pin Chuen Zing, Thais Fischer, Eliana Miranda, Maria Almeida Dias, Yung Gonzaga, Renata Lyrio R Baptista, Guilherme D Amarante, Rony Schaffel, Frederico Lisboa Nogueira, Davimar Bortucchi, Rodrigo Santucci, Sergio Brasil, Karin Z Cecyn, Vera Figueiredo, Nelson S Castro, Yana S Rabelo, Gilnara Fontinele Silva, Abrahão Elias Hallack Neto, Patricia Giacon, Milene Matedi, Diego Vila Cle, Juliana Pereira, Fernando Barroso, Renata R Souza, Henry Quintero, Denisse Castro, Brady E Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valverte, Luis Mario Villela, Ana Carolina Oliver, Laura Korin, Macarena Roa, Camila Peña, Maria Alejandra Torres Viera, Alana Von Glasenapp, Alfredo Quiroz, Cesar Samanez-Figari, Rosa Oliday Rios Jimenez, Sally Paredes, Eduardo Edelman Saul, Casey Bermack, Kelly Meza, Bryan Valcarcel, Carmino De Souza, Luis Malpica, Carlos Chiattone

Blood (2024) 144 (Supplement 1): 3064.

https://doi.org/10.1182/blood-2024-211630

Published: 2024

Journal Articles

The Number of Extranodal Sites Matters! a Proposal for a Feasible Prognostic Model in Nodal PTCL. a Collaborative Study grupo De Estudio Latino-Americano De Linfoproliferativos (GELL) & T-Cell Brazil Project (TCBP)

Thais Fischer, Eliana Miranda, Juliana Pereira, Guilherme Duffles, Jamila Vaz Tavarez, Nelson S Castro, Rodrigo Santucci, Danielle Leão Cordeiro De Farias, Sergio Brasil, Claudio G Macedo, Carolina Colaco, Renata Lyrio R Baptista, Karin Z Cecyn, Davimar Bortucchi, Gilnara Fontinele Silva, Samir Nabhan, Patricia Giacon, Rony Schaffel, Natalia Pin Chuen Zing, Frederico Lisboa Nogueira, Ademar Dantas Cunha, Diego Vila Cle, Jose D Tadeu, Vera Figueiredo, Mateus Dalló Dal Pont, Rafael Gaiolla, Nelson Hamerschlak, Eduardo Flavio Oliveira Ribeiro, Abrahão Elias Hallack Neto, Maria Almeida Dias, Yung Gonzaga, Yana S Rabelo, Larissa Lane Teixeira, Guilherme Fleury Perini, Milene Matedi, Priscilla Cury, Henry Idrobo, Denisse Castro, Brady Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valverte, Luis Mario Villela Martinez, Ana Carolina Oliver, Laura Korin, Camila Peña, Macarena Roa, Maria Alejandra Torres, Seisha Alana von Glasenapp, Alfredo Quiroz, Cesar Samanez-Figari, Rosa Oliday Rios Jimenez, Sally Paredes, Casey Bermack, Kelly Meza, Bryan Valcarcel, Carmino A Souza, Luis Malpica, Carlos Chiattone

Blood (2024) 144 (Supplement 1): 1692.

https://doi.org/10.1182/blood-2024-211164

Published: 2024

Journal Articles

Smoldering Multiple Myeloma in Latin America- Risk Stratification

Blood (2024) 144 (Supplement 1): 3774.

https://doi.org/10.1182/blood-2024-209038

Published: 2024

Journal Articles

Unveiling the Burden of Diffuse Large B Cell Lymphoma in Paraguay: A Multicenter Study on Clinical Outcomes and Diagnostic Access

Seisha Alana von Glasenapp, Lorena Cardozo, Aline Nicole Paats, Alfredo Quiroz, Maria Elvira Enciso Arrua, Mercedes Royg Arriola, Rodrigo Santacruz, Jose Zarza, Perla Noemí Britos, Leticia Rocio Jiménez, Luis Enrique Malpica Castillo

Blood (2024) 144 (Supplement 1): 1706.

https://doi.org/10.1182/blood-2024-210860

Published: 2024

Journal Articles

Survival of Patients with Multiple Myeloma Treated with Bortezomib-Based Triplets and Autologous Hematopoietic Stem Cell Transplant As First Line in Latin America

Blood (2023) 142 (Supplement 1): 3352.

https://doi.org/10.1182/blood-2023-185240

Published: 2023

Journal Articles

Renal Failure in Patients with Newly Diagnosed Multiple Myeloma Eligible for Autologous Stem Cell Transplant in LATAM - on Behalf of Gelamm

Humberto Martinez-Cordero, Maria Cynthia Fuentes Lacouture, Seisha Alana Von Glasenapp, Camila Peña, Eloisa Riva

Blood (2023) 142 (Supplement 1): 3346.

https://doi.org/10.1182/blood-2023-190668

Published: 2023

Journal Articles

Epidemiology, Clinical Features and Outcomes of Peripheral T-Cell Lymphoma in Latin America

Thais Fischer, Henry Idrobo, Astrid Pavlovsky, Denisse Castro, Brady Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valvert, Luis Mario Villela, Juliana Pereira, Carolina Oliver, Jamila Vaz Tavarez, Sergio Augusto B Brasil, Karin Z Cecyn, Nelson Castro, Renata Baptista, Samuel de S Medina, Davimar Miranda Maciel Borducchi, Marcelo Bellesso, Danielle Leao Cordeiro De Farias, Yung Bruno Gonzaga, Fernando Warley, Lorena Fiad, Laura Korin, Patricio Hernan Pereyra, Camila Peña, Maria Alejandra Torres, Carolina Valeria Mahuad, Alana Von Glasenapp, Alfredo Reinaldo Quiroz, Raimundo Gazitua, Cesar Augusto Samanez-Figari, Lautaro Sardu, Juan Pablo Arriola, Sebastian Isnardi, Juan L. Maradei, Raul Hector Gabus, Alicia I. Enrico, Luciana A Guanchiale, Florencia Negri Arangueren, Juan Ignacio García Altuve, Amalia Cerutti, Romina Penalva, Jose Ignacio Garcia Trucco, Florencia Pessolani, Virginia Gilli, Joaquin Diaz, Maria Enriqueta Martinez, Gustavo Jarchum, Gabriela Celia Perinotto, Teresa Barraza, Sergio Ciarlo, Christine Rojas, Rosa Oliday Rios Jiménez, Carmino De Souza, Martina Manni, Eliana C M CM Miranda, Massimo Federico, Bryan Valcarcel, Carlos Chiattone, Luis Enrique Malpica Castillo

Blood (2023) 142 (Supplement 1): 186.

https://doi.org/10.1182/blood-2023-187254

Published: 2023

Journal Articles

Outcomes of Newly Diagnosed Hodgkin Lymphoma Patients in 4 Academic Centers in Paraguay. the Impact to Access to PET-CT Scanning in Survival

Seisha Alana Von Glasenapp, Maria Elvira Enciso Arrua, Alfredo Quiroz, Aline Nicole Paats, Laura Morel, Leticia Rocio Jiménez, Lidiane Andino, Victor Ladislao Salinas, Bryan Valcarcel, Luis Enrique Malpica Castillo

Blood (2023) 142 (Supplement 1): 6217.

https://doi.org/10.1182/blood-2023-186387

Published: 2023

Journal Articles

Primary CNS Lymphoma in Latin America: A Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) Survey in 80 Cancer Centers in Latin America

Blood (2023) 142 (Supplement 1): 2422.

https://doi.org/10.1182/blood-2023-190477

Published: 2023

Journal Articles

Complete Response As a Determinant of Survival in Plasmablastic Lymphoma Plasmablat- GELL001 Study

Humberto Martinez-Cordero, Maria Cynthia Fuentes Lacouture, Paola Spirko, Juan Alejandro Ospina-Idárraga, Jaime Valdes Cespedes, Karen Pellon, Laura Korin, Perla R. Colunga-Pedraza, Henry Idrobo, Andrea Noboa, Luis Mario Villela, Arianna Robles, Alana Von Glasenapp, Perla N Britos, Yusaima Rodriguez, Rosa Oliday Rios Jiménez, Camila Peña, Luis Felipe Rubalcava, Jorge J. Castillo

Blood (2023) 142 (Supplement 1): 6326.

https://doi.org/10.1182/blood-2023-190960

Published: 2023

Journal Articles

Treatment Patterns and Survival of Patients with Relapsed and Refractory Classical Hodgkin Lymphoma in Latin America

Seisha Alana Von Glasenapp Gossen, Humberto Martinez-Cordero, Luis Villela, Perla Rocio Colunga-Pedraza, Fernando Perez-Jacobo, Arianna Robles, Diego Fernando Garces PAZ, Henry Idrobo, Denisse Castro, Sally Rose Paredes, Brady E Beltran, Ana Carolina Oliver, Victoria Irigoin, Juan Alejandro Ospina, Rosa Oliday Rios

Blood (2022) 140 (Supplement 1): 9429–9430.

https://doi.org/10.1182/blood-2022-171102

Published: 2022

Journal Articles

Evolution of Treatment Patterns and Prognostic Biomarkers in Latin American Patients with Chronic Lymphocytic Leukemia: A Study By the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 10918–10920.

https://doi.org/10.1182/blood-2022-168276

Published: 2022

Journal Articles

Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 6708–6710.

https://doi.org/10.1182/blood-2022-168165

Published: 2022

Journal Articles

Serum Albumin and Neutrophil-to-Lymphocyte Ratio, Two Independent Factor Predicting Survival in Patients with Follicular Lymphoma: A Multi-Institutional Retrospective Cohort of 741 FL, from the Latin American Lymphoproliferative Study Group (GELL)

Blood (2021) 138 (Supplement 1): 4515.

https://doi.org/10.1182/blood-2021-149662

Published: 2021

Journal Articles

Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell

Blood (2021) 138 (Supplement 1): 2520.

https://doi.org/10.1182/blood-2021-153875

Published: 2021

Journal Articles

Biological and Classical Prognostic Factors with Impact on Overall Survival in Patients with Early Stage (I/II) Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2021) 138 (Supplement 1): 2516.

https://doi.org/10.1182/blood-2021-152724

Published: 2021

Journal Articles

Proposal of a Novel Latin American International Prognostic Index (LATAM-IPI) for Diffuse Large B-Cell Lymphoma (DLBCL) By the Grupo Para El Estudio De Linfoproliferativos En Latino-America (GELL)

Luis Villela Villela, MDMC, Ana Ramirez-Ibarguen, MD, Brady E Beltran, MD, Camila Peña, MD, Denisse A. Castro, MD, Gladys P Agreda-Vasquez, MD, Myrna Candelaria, MDPharmD, Maria Alejandra Torres Viera, MD, Henry Idrobo, MD, Lorena Fiad, MD, Fabiola Valvert, MD, Efreen Montaño Figueroa, MD PhD, Juan Ospina Idarraga, Alana Von Glasenapp, MD, Sally Paredes, MD, Melani Otañez, MD, Fernando Perez-Jacobo, Daniela Zambrano, Humberto Martínez Cordero, MD, Virginia Otero, MD, Lidiane Andino, Mercedes Royg Arriola, MD, Maria Elvira Enciso, MD, Maria Prates, MD, Cristaldo Nancy, MD, Ivan Perdomo, MD, Maria E Cabrera, MD, María Lorena Cardozo, MD, Cristobal Augusto Frutos Ortiz, MD, Eloisa Riva, MD, Juan Antonio Choque, MD, Alfredo Reinaldo Quiroz, MD, Guilherme Fleury Perini, MD, David Gomez-Almaguer, MD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Marcos Distefano, Katerine Garcia, Carolina Feres, MD, Mariana Kalmus, Julian Cordova, Magali DelosRios, MD, Rosio Baena, MD, Luis Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD

Blood (2020) 136 (Supplement 1): 25–27.

https://doi.org/10.1182/blood-2020-142836

Published: 2020

Journal Articles

Follicular Lymphoma in Latin America: Real-World Experience from 763 Patients

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-141943

Published: 2020

NARROW

Leveraging a Novel Machine Learning Method to Predict Outcomes in Latin American (LATAM) Patients with Newly Diagnosed T and NK Cell Lymphomas (TNKL)

Using Polatuzumab Plus Chemotherapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real-World Study from the Grupo De Estudio De Linfoproliferativos De Latinoamerica (GELL)

Central Nervous System Involvement in Aggressive ATLL: Can We Predict the Risk in a Devastating Complication? Epidemiology and Clinical Features from Latin America. a Collaborative Study from Grupo De Estudio Latino-Americano De Linfoproliferativo (GELL) & T-Cell Brazil Project (TCBP)

The Number of Extranodal Sites Matters! a Proposal for a Feasible Prognostic Model in Nodal PTCL. a Collaborative Study grupo De Estudio Latino-Americano De Linfoproliferativos (GELL) & T-Cell Brazil Project (TCBP)

Smoldering Multiple Myeloma in Latin America- Risk Stratification

Unveiling the Burden of Diffuse Large B Cell Lymphoma in Paraguay: A Multicenter Study on Clinical Outcomes and Diagnostic Access

Survival of Patients with Multiple Myeloma Treated with Bortezomib-Based Triplets and Autologous Hematopoietic Stem Cell Transplant As First Line in Latin America

Renal Failure in Patients with Newly Diagnosed Multiple Myeloma Eligible for Autologous Stem Cell Transplant in LATAM - on Behalf of Gelamm

Epidemiology, Clinical Features and Outcomes of Peripheral T-Cell Lymphoma in Latin America

Outcomes of Newly Diagnosed Hodgkin Lymphoma Patients in 4 Academic Centers in Paraguay. the Impact to Access to PET-CT Scanning in Survival

Primary CNS Lymphoma in Latin America: A Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) Survey in 80 Cancer Centers in Latin America

Complete Response As a Determinant of Survival in Plasmablastic Lymphoma Plasmablat- GELL001 Study

Treatment Patterns and Survival of Patients with Relapsed and Refractory Classical Hodgkin Lymphoma in Latin America

Evolution of Treatment Patterns and Prognostic Biomarkers in Latin American Patients with Chronic Lymphocytic Leukemia: A Study By the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Serum Albumin and Neutrophil-to-Lymphocyte Ratio, Two Independent Factor Predicting Survival in Patients with Follicular Lymphoma: A Multi-Institutional Retrospective Cohort of 741 FL, from the Latin American Lymphoproliferative Study Group (GELL)

Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell

Biological and Classical Prognostic Factors with Impact on Overall Survival in Patients with Early Stage (I/II) Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Proposal of a Novel Latin American International Prognostic Index (LATAM-IPI) for Diffuse Large B-Cell Lymphoma (DLBCL) By the Grupo Para El Estudio De Linfoproliferativos En Latino-America (GELL)

Follicular Lymphoma in Latin America: Real-World Experience from 763 Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only